Elevai Labs, Inc. Common Stock (ELAB) — Cash Flow-to-Debt Ratio
Elevai Labs, Inc. Common Stock (ELAB) has a Cash Flow-to-Debt Ratio of -0.10x as of June 2026, meaning its operating cash flow of $-1.99 Million could theoretically repay 0% of its total liabilities ($19.83 Million) in one year. See financial agility of Elevai Labs, Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Elevai Labs, Inc. Common Stock Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Elevai Labs, Inc. Common Stock across 6 annual periods. For the full cash flow conversion analysis, see Elevai Labs, Inc. Common Stock (ELAB) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Elevai Labs, Inc. Common Stock (2020–2025)
Year-by-year debt coverage analysis for Elevai Labs, Inc. Common Stock. Check ELAB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.18x | $-5.93 Million | $5.03 Million | ▲ +49.8% |
| 2024 | -2.35x | $-5.49 Million | $2.33 Million | ▲ +29.7% |
| 2023 | -3.34x | $-4.56 Million | $1.36 Million | ▼ -60.4% |
| 2022 | -2.08x | $-1.59 Million | $760.87K | ▲ +32.0% |
| 2021 | -3.07x | $-660.93K | $215.62K | ▲ +42.7% |
| 2020 | -5.35x | $-217.16K | $40.61K | — |